[18F] Fluorodeoxyglucose positron-emission tomography-CT imaging of carotidynia
RR Amaravadi, SC Behr… - American journal of …, 2008 - Am Soc Neuroradiology
Carotidynia is an idiopathic syndrome characterized by pain over the carotid bifurcation
without associated luminal pathologic process. The classification of carotidynia as a distinct …
without associated luminal pathologic process. The classification of carotidynia as a distinct …
Small bowel infarcts in Degos disease
RR Amaravadi, TM Tran, R Altman, CD Scheirey - Abdominal imaging, 2008 - Springer
Degos disease is a rare idiopathic vasculopathy with multisystem involvement. We present
a previously healthy 40-year-old woman who developed spontaneous small bowel …
a previously healthy 40-year-old woman who developed spontaneous small bowel …
BAMM (BRAF Autophagy and MEK Inhibition in Melanoma): A Phase I/II Trial of Dabrafenib, Trametinib, and Hydroxychloroquine in Advanced BRAFV600-mutant …
…, JA Sosman, PA Gimotty, R Mick, RK Amaravadi - Clinical Cancer …, 2022 - AACR
… HCQ + D+T was well tolerated and produced a high RR but did not meet criteria for success
… In this difficult-to-treat population, the RR and PFS were encouraging. A randomized trial of …
… In this difficult-to-treat population, the RR and PFS were encouraging. A randomized trial of …
Tomography-CT Imaging of Carotidynia
RR Amaravadi - 2008 - Am Soc Neuroradiology
Carotidynia is an idiopathic syndrome characterized by pain over the carotid bifurcation
without associated luminal pathologic process. The classification of carotidynia as a distinct …
without associated luminal pathologic process. The classification of carotidynia as a distinct …
[PDF][PDF] Published March 20, 2008 as 10.3174/ajnr. A1013
RR Amaravadi - 2008 - Citeseer
Carotidynia is an idiopathic syndrome characterized by pain over the carotid bifurcation
without associated luminal pathologic process. The classification of carotidynia as a distinct …
without associated luminal pathologic process. The classification of carotidynia as a distinct …
Small intestine
RR Amaravadi, TM Tran, R Altman, CD Scheirey… - Pediatr Surg …, 2007 - journals.lww.com
Egbeare DM, Myers AF, Lawrance RJ. Small bowel obstruction secondary to intragastric
erosion and migration of a gastric band. J Gastrointest Surg 2008; 12: 983–984. Fenton SJ, …
erosion and migration of a gastric band. J Gastrointest Surg 2008; 12: 983–984. Fenton SJ, …
[PDF][PDF] RR Amaravadi SC Behr PD Kousoubris S. Raja
PD Kousoubris - researchgate.net
Carotidynia is an idiopathic syndrome characterized by pain over the carotid bifurcation
without associated luminal pathologic process. The classification of carotidynia as a distinct …
without associated luminal pathologic process. The classification of carotidynia as a distinct …
Phase II trial (BREAK-2) of the BRAF inhibitor dabrafenib (GSK2118436) in patients with metastatic melanoma
Purpose Dabrafenib (GSK2118436) is a potent inhibitor of mutated BRAF kinase. Our
multicenter, single-arm, phase II study assessed the safety and clinical activity of dabrafenib in …
multicenter, single-arm, phase II study assessed the safety and clinical activity of dabrafenib in …
A multicenter phase I study evaluating dual PI3K and BRAF inhibition with PX-866 and vemurafenib in patients with advanced BRAF V600–mutant solid tumors
…, J Zhao, RK Amaravadi, NB Haas, RR Kudchadkar… - Clinical Cancer …, 2018 - AACR
Purpose: The objectives of the study were to evaluate the safety of daily oral PX-866 in
combination with twice daily vemurafenib and to identify potential predictive biomarkers for this …
combination with twice daily vemurafenib and to identify potential predictive biomarkers for this …
Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer
…, RS Herati, KD Mansfield, D Patsch, RK Amaravadi… - Nature, 2015 - nature.com
… RR designed the clinical trial and was principle investigator along with SMH and AM, who
oversaw its completion. DP assisted in coordinating the trial. AM evaluated the final clinical …
oversaw its completion. DP assisted in coordinating the trial. AM evaluated the final clinical …